US20150231416A1 - Ultrasonic bath to increase tissue perfusion - Google Patents

Ultrasonic bath to increase tissue perfusion Download PDF

Info

Publication number
US20150231416A1
US20150231416A1 US14/701,863 US201514701863A US2015231416A1 US 20150231416 A1 US20150231416 A1 US 20150231416A1 US 201514701863 A US201514701863 A US 201514701863A US 2015231416 A1 US2015231416 A1 US 2015231416A1
Authority
US
United States
Prior art keywords
ultrasonic
extremity
ultrasonic bath
bath
generate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/701,863
Inventor
Robert J. Siegel
Yochai Birnbaum
Huai Luo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cedars Sinai Medical Center
University of Texas System
Original Assignee
Cedars Sinai Medical Center
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Medical Center, University of Texas System filed Critical Cedars Sinai Medical Center
Priority to US14/701,863 priority Critical patent/US20150231416A1/en
Assigned to CEDARS-SINAI MEDICAL CENTER reassignment CEDARS-SINAI MEDICAL CENTER ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LUO, HUAI, SIEGEL, ROBERT J.
Assigned to BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM reassignment BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIRNBAUM, YOCHAI
Publication of US20150231416A1 publication Critical patent/US20150231416A1/en
Priority to US15/279,185 priority patent/US20170113068A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H33/00Bathing devices for special therapeutic or hygienic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H35/00Baths for specific parts of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N2007/0004Applications of ultrasound therapy

Definitions

  • This invention relates to a method for using an ultrasonic bath to apply therapeutic ultrasonic energy to enhance tissue perfusion and collateral circulation and an apparatus for the same.
  • PVD Peripheral Vascular Disease
  • POD Peripheral Arterial Disease
  • PVD is a general term for diseases caused by occlusion or obstruction of peripheral arteries. PVD is a common disease affecting numerous patients that may lead to morbidity and suffering. The occlusion of peripheral arteries via the processes of atherosclerosis, inflammatory response, embolism, thrombus formation and diabetes mellitus may all result in PVD. PVD may cause acute or chronic ischemia in the surrounding tissues, particularly in an extremity of the affected person.
  • the acute or chronic ischemia may result in pain in the extremity (e.g., claudication), loss of sensation in the extremity, sores, wounds or ulcers that heal slowly or not at all, and tissue loss in the affected extremity.
  • Ischemia is characterized by an absolute or relative shortage of blood supply to a tissue as a result of constricted or blocked blood vessels supplying the tissue.
  • the technology available to treat ischemia in an extremity includes invasive surgical arterial bypass operations, peripheral arterial balloon angioplasty and stent placement.
  • invasive surgical arterial bypass operations include invasive surgical arterial bypass operations, peripheral arterial balloon angioplasty and stent placement.
  • the occlusive disease affects small blood vessels that are not amenable to mechanical revascularization.
  • Current technology tends to have limited long term success with high recurrence rates.
  • Medical therapy is also available; however, the benefit is limited. The most severe cases require amputation of the extremity.
  • the present invention describes a method for enhancing tissue perfusion, enhancing development of collateral blood vessels and/or enhancing collateral circulation in an extremity in need thereof, comprising: providing an ultrasonic bath; placing a subject's extremity in need of treatment in the ultrasonic bath; and using the ultrasonic bath to apply ultrasonic energy to enhance tissue perfusion, develop collateral blood vessels and/or enhance collateral circulation.
  • the method may further comprise applying heat to the extremity.
  • the extremity in need of treatment may be selected from the group consisting of an arm, hand, finger, leg, foot, toe and combinations thereof.
  • the ultrasonic bath used by the method may comprise: a basin adapted to hold media and to permit the immersion of an extremity; and one or more ultrasonic transducers to generate and transmit ultrasonic energy to the subject's extremity.
  • the basin may be about 20 inches in length, about 12 inches in width and about 40 inches in depth.
  • the ultrasonic bath may further comprise an inlet an outlet or both.
  • the ultrasonic bath may further comprise a heating element.
  • the ultrasonic bath may further comprise an ultrasonic transducer control unit.
  • the ultrasonic energy applied to the extremity may be at a frequency of about 18 kHz to about 3 mHz. In particular embodiments, the ultrasonic energy applied to the extremity may be at a frequency of about 19 kHz to about 40 kHz. In other embodiments, the ultrasonic energy may be at a power level of about 0.01 watt per cm 2 to about 20.0 watts per cm 2 . In particular embodiments, the ultrasonic energy may be at a power level of about 0.25 watt per cm 2 to about 5.0 watts per cm 2 . In one particular embodiment, the energy may be at a power level of about 1 watt per cm 2 .
  • using the ultrasonic bath may comprise applying ultrasonic energy for at least five minutes. In another embodiment, using the ultrasonic bath may comprise applying the ultrasonic energy for up to 90 minutes. In another embodiment, using the ultrasonic bath may comprise serial treatments for the extremity.
  • the method may further comprise applying heat to the extremity.
  • the present invention also describes an ultrasonic bath for enhancing tissue perfusion, enhancing development of collateral blood vessels and/or enhancing collateral circulation in an extremity in need thereof, comprising: a basin adapted to hold media and to permit the immersion of an extremity; and one or more ultrasonic transducers to generate and transmit ultrasonic energy to the subject's extremity.
  • the basin may be about 20 inches in length, about 12 inches in width and about 40 inches in depth.
  • the one or more ultrasonic transducers may be configured to generate and transmit ultrasonic energy at a frequency of about 18 kHz to about 3 mHz.
  • the one or more ultrasonic transducers may be configured to generate and transmit ultrasonic energy at a frequency of about 10 kHz to about 40 kHz.
  • the one or more ultrasonic transducers may be configured to generate and transmit the ultrasonic energy at a power level of about 0.01 watt per cm 2 to about 20.0 watts per cm 2 .
  • the one or more ultrasonic transducers may be configured to generate and transmit the ultrasonic energy at a power level of about 0.25 watt per cm 2 to about 5.0 watts per cm 2 .
  • the one or more ultrasonic transducers may be configured to generate and transmit the ultrasonic energy at a power level of about 1.0 watts per cm 2 .
  • the ultrasonic bath may further comprise an inlet, an outlet or both.
  • the ultrasonic bath may further comprise a heating element.
  • the ultrasonic bath may further comprise an ultrasonic transducer control unit.
  • FIG. 1 depicts a basin of an ultrasonic bath in accordance with an embodiment of the present invention.
  • FIG. 2 depicts an ultrasonic bath with a subject's leg immersed in the basin in accordance with an embodiment of the present invention.
  • FIG. 3 depicts an exterior view of an ultrasonic bath in accordance with an embodiment of the present invention.
  • FIG. 4 depicts a partial view ultrasonic bath with an ultrasonic transducer underneath the basin in accordance with an embodiment of the present invention.
  • Extremity refers to a limb of the body. Examples include but are not limited to arms, hands, fingers, legs, feet and toes.
  • Extremity in need of treatment refers to an extremity that is in need of treatment to enhance tissue perfusion, to enhance a body's ability to develop collateral blood vessels and/or to enhance collateral circulation.
  • Media refers to liquid, semi-solid (e.g., gel), or solid (e.g., small heads) substances capable of transferring ultrasonic energy from an ultrasonic transducer to an extremity and that will surround the extremity.
  • media include but are not limited to water, including salt water, sterile water, and deoxygenated water.
  • concentration of salt may be any appropriate concentration; for example, about 0.25% to about 10%.
  • Embodiments of the present invention provide for methods and apparatuses for using ultrasonic energy to enhance collateral circulation and thereby enhance tissue perfusion.
  • the inventors have shown herein that ultrasound exposure through a water bath to an extremity increases tissue perfusion in the tissue of the extremity.
  • the increase in tissue perfusion was found to be independent of a temperature increase in the water bath. While not wishing to be bound by any particular theory, the inventors believe that the enhanced tissue perfusion is due, in part, to mechanical vibration.
  • ultrasound increases the expression and activity of endothelial nitric oxide synthase (“eNOS”) and inducible nitric oxide synthanse (“iNOS”).
  • eNOS endothelial nitric oxide synthase
  • iNOS inducible nitric oxide synthanse
  • nitric oxide also known as endothelium derived relaxing factor (“EDRF”)
  • EDRF endothelium derived relaxing factor
  • Nitric oxide is a powerful biologic signaling molecule, which acts as a vasodilator relaxing the smooth muscle surrounding arterial blood vessels. The dilation of these arterial blood vessels increases the blood flow in the vessel and, as a result, in the surrounding tissue.
  • nitric oxide release is also linked to the formation and growth of new blood vessels in tissue. Accordingly, application of ultrasonic stimuli increases the collateral circulation and perfusion in ischemic tissues. The inventors also believe that increases in temperature associated with ultrasound may further enhance tissue perfusion.
  • an ultrasonic bath for using ultrasonic energy to enhance tissue perfusion, to enhance the body's ability to develop collateral blood vessels and/or to enhance collateral circulation in an extremity in need thereof.
  • the ultrasonic bath may comprise a basin configured with one or more ultrasonic transducers to generate and transmit ultrasound energy to an extremity, wherein the basin is adapted to hold media and to permit immersion of an extremity.
  • the ultrasonic bath may further comprise a transducer control unit to control the amplitude, frequency, power and/or duration of ultrasonic energy.
  • the ultrasonic bath may also further comprise an inlet and/or an outlet to fill the basin with media or to drain the basin of the media. In a particular embodiment, the inlet and outlet may be the same element on the ultrasonic bath to serve a dual purpose.
  • the basin may be made from any appropriate material known in the art.
  • the basin may be made of stainless steel.
  • the basin may be any suitable size and shape that permits the immersion of an extremity.
  • the size and shape of the basin may be configured particularly for use with a particular extremity.
  • the basin may be about 20 inches in length, about 12 inches in width and about 40 inches in depth.
  • the basin size of this embodiment may be particularly useful for immersion and treatment of a leg.
  • the basin is adapted to permit the immersion of an entire extremity.
  • the ultrasonic transducer may be adapted to generate and transmit ultrasonic energy at a frequency of about 18 kHz to about 3 mHz. In some embodiments the frequency may be about 19 kHz to about 40 kHz. In other embodiments, the ultrasonic transducer may be adapted to generate and transmit a power output of about 0.01 watt per cm 2 to about 20.0 watts per cm 2 . In particular embodiments, the ultrasonic transducer may be adapted to generate and transmit a power output of about 0.25 waft per cm 2 to about 5.0 watts per cm 2 . In one particular embodiment, the power output may be about 1 watt per cm 2 .
  • the media placed in the basin allows for uniform transmission of ultrasonic energy from the ultrasonic transducer to the extremity that is immersed in the media and surrounded by the media.
  • the basin may further comprise a heating element to heat media that is placed info the basin.
  • the ultrasonic transducer may also be used as a heating element, by its transfer of ultrasound energy into the media.
  • the heating element may be a separate element to provide heat to the media.
  • Additional embodiments of the present invention provide for methods of using ultrasonic energy to enhance tissue perfusion, to enhance the body's ability to develop collateral vessels, and/or to enhance collateral circulation in an extremity in need thereof.
  • the method comprises providing an ultrasonic bath as described herein, placing an extremity in need of treatment into the ultrasonic bath and using the ultrasonic bath to apply ultrasonic energy to the extremity.
  • the extremity in need of treatment is placed in the inventive ultrasonic bath and ultrasonic energy is applied to the extremity for at least 5 minutes.
  • the extremity in need of treatment is placed in the inventive ultrasonic bath and ultrasonic energy is applied to the extremity for up to 90 minutes.
  • the use of a lower power level may allow for a longer period of treatment.
  • treatment for more than 90 minutes may be performed.
  • the extremity in need of treatment is placed in the ultrasonic bath and ultrasonic energy is applied to the extremity for about 15, 30, 45, 60, or 75 minutes.
  • serial treatments for the extremity in need of treatment may be performed to enhance tissue perfusion, to enhance the body's ability to develop collateral vessels, and/or to enhance collateral circulation in an ischemic extremity.
  • the inventive ultrasonic bath may be provided to a patient for home use and the patient may be instructed to use the ultrasonic bath several times a day (e.g., four times a day).
  • a patient may visit an outpatient facility to receive the treatment using the ultrasonic bath and thus treatment may be one or more times per week (e.g., once per week, three times per week, five time per week).
  • treatment may be one or more times per week (e.g., once per week, three times per week, five time per week).
  • One of skill in the art will be able to determine the length, number, and frequency of treatments that are appropriate for an extremity in need of treatment. Factors to consider may include but are not limited to the subjects age, health, extent of arterial occlusion, degree of the peripheral arterial disease, degree of the ischemia, and energy level of the ultrasonic bath.
  • the method may further comprise the application of heat to the extremity.
  • appropriate temperatures of heat include but are not limited to from room temperature (e.g., about 20° C.) to a temperature that does not cause a high level of discomfort or burns to the extremity (e.g., about 43° C. to 48° C.). In various embodiments, the temperature may be about 20° C., 25° C., 30° C., 35° C., 40° C., about 45° C.
  • Application of heat may be performed by heating the media in the ultrasonic bath. Heating the media may be performed before placing the extremity in need of treatment into the ultrasonic bath or while the extremity in need to treatment is immersed in the media in the ultrasonic bath. In other embodiments, the application of heat to the extremity may be performed before the extremity receives the ultrasound treatment or after the extremity received the ultrasound treatment.
  • a transcutaneous oxygen tension monitor was placed on the left extremity and the corresponding right extremity. Measurement of the transcutaneous oxygen tension is a method of evaluating blood flow in settings where tissue viability and the blood flow are of concern. If the transcutaneous oxygen tension is too low, a surgeon may decide to amputate the extremity. Since the transcutaneous oxygen tension displayed by the transcutaneous oxygen tension monitor changes very frequently, a series of measurements was recorded over a short period of time (e.g., 10 seconds, 30 seconds, 1 minute, etc.) and the mean transcutaneous oxygen tension was determined and used as it provides a better indication of the transcutaneous oxygen tension.
  • the transcutaneous oxygen tension in both the left extremity and the corresponding right extremity were measured prior to immersing the left extremity into the ultrasonic bath.
  • the left extremity was immersed in the apparatus containing water and ultrasound was applied through the water to the extremity for five minutes.
  • the transcutaneous oxygen tension was measured in both the left extremity and the corresponding right extremity after removing the left extremity from the apparatus. Again, a series of measurements was taken and the mean value was used. The right extremity did not receive treatment.
  • FIG. 1 depicts a top view of one embodiment of the ultrasonic bath 100 .
  • the ultrasonic bath comprises a basin 101 , an outlet 102 , an ultrasound transducer 103 that is underneath the basin 101 , heating elements 104 that are also underneath the basin 101 , and a transducer control unit 105 .
  • FIG. 2 depicts a subject's leg 201 placed in the ultrasonic bath 100 .
  • the basin 101 and a transducer control unit 105 are also shown.
  • FIG. 3 depicts an exterior view of an ultrasonic bath 100 .
  • An outlet 102 is used to drain the basin after use.
  • a transducer control unit 105 is used to control the amplitude, frequency, power and/or duration of ultrasonic energy. Also shown is the transducer 103 underneath the basin 101 , as well as heating elements 104 being underneath the basin 101 .
  • FIG. 4 depicts a representation of an ultrasonic bath 101 , with an ultrasonic transducer 103 underneath the basin 101 .
  • the outlet 102 allows for drainage of the basin.
  • Heating elements 104 are also underneath the basin.
  • additional ultrasonic transducers 103 are placed underneath the basin 101 (not shown).
  • one or more transducers 103 are place on the side of the basin (not shown).
  • one or more transducers 103 are immersed in the basin 101 (not shown).

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Cosmetics (AREA)

Abstract

The present invention describes a method of using an ultrasonic bath to enhance tissue perfusion, enhance the development of collateral blood vessels and/or enhance collateral circulation in an extremity in need thereof. Also described is an ultrasonic bath for the inventive method.

Description

    FIELD OF INVENTION
  • This invention relates to a method for using an ultrasonic bath to apply therapeutic ultrasonic energy to enhance tissue perfusion and collateral circulation and an apparatus for the same.
  • BACKGROUND
  • All publications herein are incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference. The following description includes information that may be useful in understanding the present invention. It is not an admission that any of the information provided herein is prior art or relevant to the presently claimed invention, or that any publication specifically or implicitly referenced is prior art.
  • Peripheral Vascular Disease (“PVD”), also referred to as Peripheral Arterial Disease (“PAD”), is a general term for diseases caused by occlusion or obstruction of peripheral arteries. PVD is a common disease affecting numerous patients that may lead to morbidity and suffering. The occlusion of peripheral arteries via the processes of atherosclerosis, inflammatory response, embolism, thrombus formation and diabetes mellitus may all result in PVD. PVD may cause acute or chronic ischemia in the surrounding tissues, particularly in an extremity of the affected person. The acute or chronic ischemia may result in pain in the extremity (e.g., claudication), loss of sensation in the extremity, sores, wounds or ulcers that heal slowly or not at all, and tissue loss in the affected extremity. Ischemia is characterized by an absolute or relative shortage of blood supply to a tissue as a result of constricted or blocked blood vessels supplying the tissue.
  • The technology available to treat ischemia in an extremity includes invasive surgical arterial bypass operations, peripheral arterial balloon angioplasty and stent placement. However, in many patients and especially in those with diabetes mellitus, the occlusive disease affects small blood vessels that are not amenable to mechanical revascularization. Current technology tends to have limited long term success with high recurrence rates. Medical therapy is also available; however, the benefit is limited. The most severe cases require amputation of the extremity.
  • Thus, there is a need in the art for a method and a device for non-invasive treatment of ischemia and/or PVD. Further, there is a need for technology to enhance perfusion to the extremities, to enhance a body's ability to develop collateral blood vessels and to enhance collateral circulation.
  • SUMMARY OF THE INVENTION
  • The following embodiments and aspects thereof are described and illustrated in conjunction with compositions and methods which are meant to be exemplary and illustrative, not limiting in scope.
  • The present invention describes a method for enhancing tissue perfusion, enhancing development of collateral blood vessels and/or enhancing collateral circulation in an extremity in need thereof, comprising: providing an ultrasonic bath; placing a subject's extremity in need of treatment in the ultrasonic bath; and using the ultrasonic bath to apply ultrasonic energy to enhance tissue perfusion, develop collateral blood vessels and/or enhance collateral circulation. The method may further comprise applying heat to the extremity. In various embodiments, the extremity in need of treatment may be selected from the group consisting of an arm, hand, finger, leg, foot, toe and combinations thereof.
  • The ultrasonic bath used by the method may comprise: a basin adapted to hold media and to permit the immersion of an extremity; and one or more ultrasonic transducers to generate and transmit ultrasonic energy to the subject's extremity. In one embodiment, the basin may be about 20 inches in length, about 12 inches in width and about 40 inches in depth. In one embodiment, the ultrasonic bath may further comprise an inlet an outlet or both. In another embodiment, the ultrasonic bath may further comprise a heating element. In another embodiment, the ultrasonic bath may further comprise an ultrasonic transducer control unit.
  • In various embodiments, the ultrasonic energy applied to the extremity may be at a frequency of about 18 kHz to about 3 mHz. In particular embodiments, the ultrasonic energy applied to the extremity may be at a frequency of about 19 kHz to about 40 kHz. In other embodiments, the ultrasonic energy may be at a power level of about 0.01 watt per cm2 to about 20.0 watts per cm2. In particular embodiments, the ultrasonic energy may be at a power level of about 0.25 watt per cm2 to about 5.0 watts per cm2. In one particular embodiment, the energy may be at a power level of about 1 watt per cm2.
  • In one embodiment, using the ultrasonic bath may comprise applying ultrasonic energy for at least five minutes. In another embodiment, using the ultrasonic bath may comprise applying the ultrasonic energy for up to 90 minutes. In another embodiment, using the ultrasonic bath may comprise serial treatments for the extremity.
  • In another embodiment, the method may further comprise applying heat to the extremity.
  • The present invention also describes an ultrasonic bath for enhancing tissue perfusion, enhancing development of collateral blood vessels and/or enhancing collateral circulation in an extremity in need thereof, comprising: a basin adapted to hold media and to permit the immersion of an extremity; and one or more ultrasonic transducers to generate and transmit ultrasonic energy to the subject's extremity. The basin may be about 20 inches in length, about 12 inches in width and about 40 inches in depth. In various embodiments, the one or more ultrasonic transducers may be configured to generate and transmit ultrasonic energy at a frequency of about 18 kHz to about 3 mHz. In particular embodiments, the one or more ultrasonic transducers may be configured to generate and transmit ultrasonic energy at a frequency of about 10 kHz to about 40 kHz. The one or more ultrasonic transducers may be configured to generate and transmit the ultrasonic energy at a power level of about 0.01 watt per cm2 to about 20.0 watts per cm2. In particular embodiments, the one or more ultrasonic transducers may be configured to generate and transmit the ultrasonic energy at a power level of about 0.25 watt per cm2 to about 5.0 watts per cm2. In one particular embodiment, the one or more ultrasonic transducers may be configured to generate and transmit the ultrasonic energy at a power level of about 1.0 watts per cm2.
  • The ultrasonic bath may further comprise an inlet, an outlet or both. In another embodiment, the ultrasonic bath may further comprise a heating element. In another embodiment, the ultrasonic bath may further comprise an ultrasonic transducer control unit.
  • Other features and advantages of the invention will become apparent from the following detailed description, taken in conjunction with the accompanying drawings, which illustrate, by way of example, various features of embodiments of the invention.
  • BRIEF DESCRIPTION OF THE FIGURES
  • Exemplary embodiments are illustrated in referenced figures. It is intended that the embodiments and figures disclosed herein are to be considered illustrative rather than restrictive.
  • FIG. 1 depicts a basin of an ultrasonic bath in accordance with an embodiment of the present invention.
  • FIG. 2 depicts an ultrasonic bath with a subject's leg immersed in the basin in accordance with an embodiment of the present invention.
  • FIG. 3 depicts an exterior view of an ultrasonic bath in accordance with an embodiment of the present invention.
  • FIG. 4 depicts a partial view ultrasonic bath with an ultrasonic transducer underneath the basin in accordance with an embodiment of the present invention.
  • DESCRIPTION OF THE INVENTION
  • All references cited herein are incorporated by reference in their entirely as though fully set forth. Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Singleton et al., Dictionary of Microbiology and Molecular Biology 3rd ed., J. Wiley & Sons (New York, N.Y. 2001); and March, Advanced Organic Chemistry Reactions, Mechanisms and Structure 5th ed., J. Wiley & Sons (New York, N.Y. 2001).
  • One skilled in the art will recognize many methods and materials similar or equivalent to those described herein, which could be used in the practice of the present invention. Indeed, the present invention is in no way limited to the methods and materials described. For purposes of the present invention, the following terms are defined below.
  • “Extremity” as used herein refers to a limb of the body. Examples include but are not limited to arms, hands, fingers, legs, feet and toes.
  • “Extremity in need of treatment” as used herein refers to an extremity that is in need of treatment to enhance tissue perfusion, to enhance a body's ability to develop collateral blood vessels and/or to enhance collateral circulation.
  • “Media” as used herein refers to liquid, semi-solid (e.g., gel), or solid (e.g., small heads) substances capable of transferring ultrasonic energy from an ultrasonic transducer to an extremity and that will surround the extremity. Examples of media include but are not limited to water, including salt water, sterile water, and deoxygenated water. In embodiments wherein salt water is used, the concentration of salt may be any appropriate concentration; for example, about 0.25% to about 10%.
  • Embodiments of the present invention provide for methods and apparatuses for using ultrasonic energy to enhance collateral circulation and thereby enhance tissue perfusion.
  • The inventors have shown herein that ultrasound exposure through a water bath to an extremity increases tissue perfusion in the tissue of the extremity. The increase in tissue perfusion was found to be independent of a temperature increase in the water bath. While not wishing to be bound by any particular theory, the inventors believe that the enhanced tissue perfusion is due, in part, to mechanical vibration. Furthermore, the inventors have previously shown that ultrasound increases the expression and activity of endothelial nitric oxide synthase (“eNOS”) and inducible nitric oxide synthanse (“iNOS”). (See Atar et al., “Low-frequency ultrasound increases activity and tissue content of nitric oxide synthase in acute limb ischemia in rabbits,” World Congress of Cardiology 2006, Barcelona Spain. P595.) The increased expression of these enzymes, particularly eNOS, corresponds to an increase in the release of nitric oxide, also known as endothelium derived relaxing factor (“EDRF”), within the tissue's blood vessels. Nitric oxide is a powerful biologic signaling molecule, which acts as a vasodilator relaxing the smooth muscle surrounding arterial blood vessels. The dilation of these arterial blood vessels increases the blood flow in the vessel and, as a result, in the surrounding tissue. Moreover, nitric oxide release is also linked to the formation and growth of new blood vessels in tissue. Accordingly, application of ultrasonic stimuli increases the collateral circulation and perfusion in ischemic tissues. The inventors also believe that increases in temperature associated with ultrasound may further enhance tissue perfusion.
  • Application of ultrasound with a hand-held transducer is limited due to the narrow field of application, which makes application of ultrasound to an entire extremity difficult and time consuming. Moreover, hand-held transducers are likely ineffective in delivering uniform increase in blood flow to the extremity.
  • As such, various embodiments of the present invention provide for an ultrasonic bath for using ultrasonic energy to enhance tissue perfusion, to enhance the body's ability to develop collateral blood vessels and/or to enhance collateral circulation in an extremity in need thereof. The ultrasonic bath may comprise a basin configured with one or more ultrasonic transducers to generate and transmit ultrasound energy to an extremity, wherein the basin is adapted to hold media and to permit immersion of an extremity. The ultrasonic bath may further comprise a transducer control unit to control the amplitude, frequency, power and/or duration of ultrasonic energy. The ultrasonic bath may also further comprise an inlet and/or an outlet to fill the basin with media or to drain the basin of the media. In a particular embodiment, the inlet and outlet may be the same element on the ultrasonic bath to serve a dual purpose.
  • The basin may be made from any appropriate material known in the art. In one embodiment, the basin may be made of stainless steel. The basin may be any suitable size and shape that permits the immersion of an extremity. In various embodiments, the size and shape of the basin may be configured particularly for use with a particular extremity. In one particular embodiment, the basin may be about 20 inches in length, about 12 inches in width and about 40 inches in depth. The basin size of this embodiment may be particularly useful for immersion and treatment of a leg. In another particular embodiment, the basin is adapted to permit the immersion of an entire extremity.
  • In various embodiments, the ultrasonic transducer may be adapted to generate and transmit ultrasonic energy at a frequency of about 18 kHz to about 3 mHz. In some embodiments the frequency may be about 19 kHz to about 40 kHz. In other embodiments, the ultrasonic transducer may be adapted to generate and transmit a power output of about 0.01 watt per cm2 to about 20.0 watts per cm2. In particular embodiments, the ultrasonic transducer may be adapted to generate and transmit a power output of about 0.25 waft per cm2 to about 5.0 watts per cm2. In one particular embodiment, the power output may be about 1 watt per cm2. The media placed in the basin allows for uniform transmission of ultrasonic energy from the ultrasonic transducer to the extremity that is immersed in the media and surrounded by the media.
  • In a further embodiment, the basin may further comprise a heating element to heat media that is placed info the basin. In one embodiment, the ultrasonic transducer may also be used as a heating element, by its transfer of ultrasound energy into the media. In another embodiment, the heating element may be a separate element to provide heat to the media.
  • Additional embodiments of the present invention provide for methods of using ultrasonic energy to enhance tissue perfusion, to enhance the body's ability to develop collateral vessels, and/or to enhance collateral circulation in an extremity in need thereof. The method comprises providing an ultrasonic bath as described herein, placing an extremity in need of treatment into the ultrasonic bath and using the ultrasonic bath to apply ultrasonic energy to the extremity. In one embodiment, the extremity in need of treatment is placed in the inventive ultrasonic bath and ultrasonic energy is applied to the extremity for at least 5 minutes. In another embodiment, the extremity in need of treatment is placed in the inventive ultrasonic bath and ultrasonic energy is applied to the extremity for up to 90 minutes. The use of a lower power level may allow for a longer period of treatment. Thus, in some embodiments, treatment for more than 90 minutes may be performed. In other embodiments, the extremity in need of treatment is placed in the ultrasonic bath and ultrasonic energy is applied to the extremity for about 15, 30, 45, 60, or 75 minutes. One of skill in the art will be able to determine the appropriate period of treatment. In further embodiments, serial treatments for the extremity in need of treatment may be performed to enhance tissue perfusion, to enhance the body's ability to develop collateral vessels, and/or to enhance collateral circulation in an ischemic extremity. For example, the inventive ultrasonic bath may be provided to a patient for home use and the patient may be instructed to use the ultrasonic bath several times a day (e.g., four times a day). In other embodiments, a patient may visit an outpatient facility to receive the treatment using the ultrasonic bath and thus treatment may be one or more times per week (e.g., once per week, three times per week, five time per week). One of skill in the art will be able to determine the length, number, and frequency of treatments that are appropriate for an extremity in need of treatment. Factors to consider may include but are not limited to the subjects age, health, extent of arterial occlusion, degree of the peripheral arterial disease, degree of the ischemia, and energy level of the ultrasonic bath.
  • In a further embodiment, the method may further comprise the application of heat to the extremity. Examples of appropriate temperatures of heat include but are not limited to from room temperature (e.g., about 20° C.) to a temperature that does not cause a high level of discomfort or burns to the extremity (e.g., about 43° C. to 48° C.). In various embodiments, the temperature may be about 20° C., 25° C., 30° C., 35° C., 40° C., about 45° C. Application of heat may be performed by heating the media in the ultrasonic bath. Heating the media may be performed before placing the extremity in need of treatment into the ultrasonic bath or while the extremity in need to treatment is immersed in the media in the ultrasonic bath. In other embodiments, the application of heat to the extremity may be performed before the extremity receives the ultrasound treatment or after the extremity received the ultrasound treatment.
  • EXAMPLE
  • The following examples are provided to better illustrate the claimed invention and is not to be interpreted as limiting the scope of the invention. To the extent that specific materials are mentioned, it is merely for purposes of illustration and is not intended to limit the invention. One skilled in the art may develop equivalent means or reactants without the exercise of inventive capacity and without departing from the scope of the invention.
  • Example 1 Transcutaneous Application of Ultrasound and Measurement of Transcutaneous Oxygen Tension
  • A transcutaneous oxygen tension monitor was placed on the left extremity and the corresponding right extremity. Measurement of the transcutaneous oxygen tension is a method of evaluating blood flow in settings where tissue viability and the blood flow are of concern. If the transcutaneous oxygen tension is too low, a surgeon may decide to amputate the extremity. Since the transcutaneous oxygen tension displayed by the transcutaneous oxygen tension monitor changes very frequently, a series of measurements was recorded over a short period of time (e.g., 10 seconds, 30 seconds, 1 minute, etc.) and the mean transcutaneous oxygen tension was determined and used as it provides a better indication of the transcutaneous oxygen tension.
  • The transcutaneous oxygen tension in both the left extremity and the corresponding right extremity were measured prior to immersing the left extremity into the ultrasonic bath. The left extremity was immersed in the apparatus containing water and ultrasound was applied through the water to the extremity for five minutes. The transcutaneous oxygen tension was measured in both the left extremity and the corresponding right extremity after removing the left extremity from the apparatus. Again, a series of measurements was taken and the mean value was used. The right extremity did not receive treatment.
  • In the treatment group (i.e., left extremities) of 28, 23 showed 7-52% increase in the transcutaneous oxygen tension in the extremity; 2 showed a decrease in the transcutaneous oxygen tension in the extremity; and 1 showed no significant change in the transcutaneous oxygen tension in the extremity. In the non-treatment group (i.e., right extremities) of 23, 14 showed a 5-70% increase of transcutaneous oxygen tension in the extremity; 5 showed a decrease in the transcutaneous oxygen tension in the extremity; and 4 showed no significant change in the transcutaneous oxygen tension in the extremity. Although the corresponding right extremity was not treated, treatment in the left extremity was able to affect the blood vessels of the corresponding untreated extremity. The details of the tests are summarized in tables 1 and 2.
  • TABLE 1
    Upper Extremities
    L. arm L. palm L. index R. arm R. palm R. index
    pre Post pre Post pre Post pre Post pre Post pre Post
    USD USD USD USD USD USD USD USD USD USD USD USD
    Case 1 39 84 115 153 52 163 23 60 71 111 74 37
    31 74 112 103 55 118 25 58 66 119 59 35
    33 92 109 83 50 78 38 57 99 120 56 34
    40 67 107 75 43 66 44 59 91 114 55 33
    45 63 106 69 40 63 59 85 117 33
    50 64 103 64 36 60 63 84 114 32
    49 50 101 69 36 81 58 35
    57 96 37
    55 91 36
    Mean 44.3 70.6 104.4 88.0 42.8 89.9 32.5 59.1 82.7 115.8 61.0 34.1
    incre37% incre52% incre45% incre29%
    Case 2 14 32 77 99 75 77 8 50 74 77 88 52
    32 25 78 92 62 70 9 50 71 76 74 51
    21 30 77 88 57 67 15 52 73 77 69 51
    22 40 65 85 55 63 12 49 75 76 65 49
    26 46 58 82 51 59 18 54 75 76 62 48
    32 50 56 78 49 57 21 59 76 75 58 48
    37 50 58 77 46 54 29 63 79 74 55 47
    40 56
    Mean 28.0 41.1 67.0 85.9 56.4 63.9 16.0 53.9 74.7 75.9 67.3 49.4
    incre32% incre22% incre12% incre70%
    Case 3 38 64 150 156 82 94 95 95 153 149
    35 44 150 153 70 86 84 99 153 149
    42 45 150 152 67 79 90 100 153 149
    44 50 142 151 64 72 96 114 137 149
    49 53 150 150 62 97 90 132 151
    54 55 150 149 59 88 128 151
    56 150 54
    59 52
    56
    Mean 48.1 51.8 148.9 151.8 63.8 82.8 92.4 97.7 142.7 149.7
    incre7% incre23% incre5% incre5%
  • TABLE 2
    Lower Extremities
    R. knee R. ankle R. foot L. knee L. ankle L. foot
    pre Post pre Post pre Post pre Post pre Post pre Post
    USD USD USD USD USD USD USD USD USD USD USD USD
    Case 4 33 73 73 58 11 70 13 15 46 68 44 68
    38 75 66 56 33 65 38 61 51 47 46
    53 75 67 56 40 66 39 66 67 44 40
    53 74 57 59 35 67 38 27 37
    50 73 51 55 37 64 36
    55 71 52 53 42 63 38
    70 41
    42
    Mean 47.0 73.0 61.0 56.2 33.0 65.8 32.0 15.0 57.7 53.3 45.0 43.5
    incre35% incre50%
    Case 5 46 66 51 55 57 62 74 60 40 85
    42 68 55 53 47 54 40 65 48 30
    53 71 48 55 59 60 51 67 53 52
    53 73 47 55 65 63 57 71 48
    57 74 54 56 66 71 47
    63 72 51 54 65 57
    52.3 70.7 51.0 54.7 57.0 61.7 55.5 66.8 47.0 53.2
    incre26% incre7% incre7% incre17% incre11%
    Case 6 99 39 64 31 21 27 91 55 31 39
    92 41 47 30 32 42 81 59 36 38
    45 39 29 34 45 72 61 30 38
    28 29 31 46 62 39 37
    47 63 37 37
    38
    Mean 95.5 41.7 44.5 29.8 29.5 41.4 81.3 60.0 35.2 37.8
    incre29%
    Case 7 16 54 26 42 33 36 88 58 45 58 27 69
    18 58 44 46 43 46 19 56 37 61 37 78
    39 62 43 41 35 52 31 56 54 61 24 79
    40 64 34 41 32 53 39 58 57 64 25 79
    40 66 27 36 53 50 57 46 64 26 81
    47 68 36 51 57 55 46 64 56 77
    67 58 49 66
    Mean 33.3 62.7 34.8 40.3 35.8 48.5 47.3 56.9 47.7 62.6 32.5 77.2
    incre47% incre14% incre26% incre17% incre24% incre58%
    Case 8 39 71 67 67 64 84 45 70 42 78 57 67
    57 67 60 68 60 70 46 67 66 74 61 68
    62 72 57 65 57 66 45 53 70 74 64 65
    64 69 58 63 54 63 44 88 69 75 64 65
    64 72 58 64 53 61 46 64 67 74 63 65
    67 73 58 65 52 59 50 68 88 75 63 66
    77 59 52 74 72 79 66
    Mean 58.8 71.6 59.7 65.3 56.7 66.0 46.9 69.1 67.7 75.6 62.0 66.0
    incre18% incre8% incre14% incre32% incre10% incre6%
    Case 9 34 53 29 47 43 53 42 55
    44 59 31 42 48 54 55 56
    48 60 31 38 51 53 60 54
    51 61 32 34 51 52 61 53
    52 61 30 31 51 51 60 51
    Mean 45.8 58.8 30.6 38.4 48.8 52.6 55.6 53.8
    incre22% incre20% incre7%
    Case 10 65 74 63 58 47 25
    68 71 56 60 15 36
    68 76 52 51 24 45
    Mean 67.0 73.7 57.0 53.0 28.7 35.3
    incre9% incre19%
  • Example 2
  • In accordance with one embodiment of the invention, FIG. 1 depicts a top view of one embodiment of the ultrasonic bath 100. As shown, the ultrasonic bath comprises a basin 101, an outlet 102, an ultrasound transducer 103 that is underneath the basin 101, heating elements 104 that are also underneath the basin 101, and a transducer control unit 105.
  • In accordance with another embodiment of the invention, FIG. 2 depicts a subject's leg 201 placed in the ultrasonic bath 100. The basin 101 and a transducer control unit 105 are also shown.
  • In accordance with another embodiment of the invention, FIG. 3 depicts an exterior view of an ultrasonic bath 100. An outlet 102 is used to drain the basin after use. A transducer control unit 105 is used to control the amplitude, frequency, power and/or duration of ultrasonic energy. Also shown is the transducer 103 underneath the basin 101, as well as heating elements 104 being underneath the basin 101.
  • In accordance with another embodiment of the invention, FIG. 4 depicts a representation of an ultrasonic bath 101, with an ultrasonic transducer 103 underneath the basin 101. The outlet 102 allows for drainage of the basin. Heating elements 104 are also underneath the basin.
  • In another embodiment, additional ultrasonic transducers 103 are placed underneath the basin 101 (not shown). In an alternative embodiment, one or more transducers 103 are place on the side of the basin (not shown). Alternatively, one or more transducers 103 are immersed in the basin 101 (not shown).
  • Various embodiments of the invention are described above in the Detailed Description. While these descriptions directly describe the above embodiments, it is understood that those skilled in the art may conceive modifications and/or variations to the specific embodiments shown and described herein. Any such modifications or variations that fall within the purview of this description are intended to be included therein as well. Unless specifically noted, it is the intention of the inventors that the words and phrases in the specification and claims be given the ordinary and accustomed meanings to those of ordinary skill in the applicable art(s).
  • The foregoing description of various embodiments of the invention known to the applicant at this time of filing the application has been presented and is intended for the purposes of illustration and description. The present description is not intended to be exhaustive nor limit the invention to the precise form disclosed and many modifications and variations are possible in the light of the above teachings. The embodiments described serve to explain the principles of the invention and its practical application and to enable others skilled in the art to utilize the invention in various embodiments and with various modifications as are suited to the particular use contemplated. Therefore, it is intended that the invention not be limited to the particular embodiments disclosed for carrying out the invention.
  • While particular embodiments of the present invention have been shown and described, it will be obvious to those skilled in the art that, based upon the teachings herein, changes and modifications may be made without departing from this invention and its broader aspects and, therefore, the appended claims are to encompass within their scope all such changes and modifications as are within the true spirit and scope of this invention. It will be understood by those within the art that, in general, terms used herein are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.).

Claims (21)

1. A method for enhancing the oxygen level in an extremity, comprising:
providing a source of ultrasonic energy; and
applying ultrasonic energy to the extremity, thereby enhancing the oxygen level in the extremity.
2-15. (canceled)
16. An ultrasonic bath for enhancing the oxygen level in an extremity, comprising:
a basin shaped and sized to hold media and to permit the immersion of an extremity; and
one or more ultrasonic transducers configured to generate and transmit ultrasonic energy to the extremity.
17. The ultrasonic bath of claim 16, wherein the basin is about 20 inches in length, about 12 inches in width and about 40 inches in depth.
18. The ultrasonic bath of claim 16, wherein the one or more ultrasonic transducers are configured to generate and transmit ultrasonic energy at a frequency of about 18 kHz to about 3 mHz.
19. The ultrasonic bath of claim 16, wherein the one or more ultrasonic transducers are configured to generate and transmit the ultrasonic energy at a power level of about 0.01 watt per cm2 to about 20.0 watts per cm2.
20. The ultrasonic bath of claim 16, wherein the one or more ultrasonic transducers are configured to generate and transmit the ultrasonic energy at a power level of about 0.25 watt per cm2 to about 5.0 watts per cm2.
21. The ultrasonic bath of claim 16, further comprising an inlet, an outlet or both.
22. The ultrasonic bath of claim 16, further comprising a heating element.
23. The ultrasonic bath of claim 16, further comprising an ultrasonic transducer control unit.
24. The ultrasonic bath of claim 23, wherein the transducer control unit is coupled to the one or more ultrasonic transducers operative to selectively control the frequency and duration of the ultrasonic energy transmitted to the extremity during operation.
25. The ultrasonic bath of claim 23, wherein the transducer control unit is configured to allow an operator to adjust the frequency and duration of the ultrasonic energy transmitted to the extremity during operation.
26. The ultrasonic bath of claim 16, wherein the one or more ultrasonic transducers are configured to generate and transmit ultrasonic energy to the extremity at a plurality of frequencies during operation.
27. The ultrasonic bath of claim 16, wherein the extremity is an ischemic extremity.
28. The ultrasonic bath of claim 16, wherein the extremity is selected from the group consisting of an arm, hand, finger, leg, foot, toe and combinations thereof.
29. The ultrasonic bath of claim 16, wherein the media comprises a saltwater solution having a salt concentration of between 0.25% and 10%.
30. The ultrasonic bath of claim 16, wherein the one or more ultrasonic transducers are configured to generate and transmit ultrasonic energy at a frequency of about 18 kHz to about 3 MHz.
31. The ultrasonic bath of claim 16, wherein the one or more ultrasonic transducers are configured to generate and transmit ultrasonic energy at a frequency of about 19 kHz to about 40 KHz.
32. The ultrasonic bath of claim 16, wherein the media comprises a semi-solid or a solid.
33. The ultrasonic bath of claim 32, wherein the semi-solid is a gel.
34. The ultrasonic bath of claim 32, wherein the solid is small beads.
US14/701,863 2006-12-19 2015-05-01 Ultrasonic bath to increase tissue perfusion Abandoned US20150231416A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US14/701,863 US20150231416A1 (en) 2006-12-19 2015-05-01 Ultrasonic bath to increase tissue perfusion
US15/279,185 US20170113068A1 (en) 2006-12-19 2016-09-28 Ultrasonic bath to increase tissue perfusion

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87070106P 2006-12-19 2006-12-19
PCT/US2007/088118 WO2008077096A2 (en) 2006-12-19 2007-12-19 Ultrasonic bath to increase tissue perfusion
US52004109A 2009-06-18 2009-06-18
US14/701,863 US20150231416A1 (en) 2006-12-19 2015-05-01 Ultrasonic bath to increase tissue perfusion

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US12/520,041 Continuation US9050448B2 (en) 2006-12-19 2007-12-19 Ultrasonic bath to increase tissue perfusion
PCT/US2007/088118 Continuation WO2008077096A2 (en) 2006-12-19 2007-12-19 Ultrasonic bath to increase tissue perfusion

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/279,185 Continuation US20170113068A1 (en) 2006-12-19 2016-09-28 Ultrasonic bath to increase tissue perfusion

Publications (1)

Publication Number Publication Date
US20150231416A1 true US20150231416A1 (en) 2015-08-20

Family

ID=39537069

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/520,041 Expired - Fee Related US9050448B2 (en) 2006-12-19 2007-12-19 Ultrasonic bath to increase tissue perfusion
US14/701,863 Abandoned US20150231416A1 (en) 2006-12-19 2015-05-01 Ultrasonic bath to increase tissue perfusion
US15/279,185 Abandoned US20170113068A1 (en) 2006-12-19 2016-09-28 Ultrasonic bath to increase tissue perfusion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/520,041 Expired - Fee Related US9050448B2 (en) 2006-12-19 2007-12-19 Ultrasonic bath to increase tissue perfusion

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/279,185 Abandoned US20170113068A1 (en) 2006-12-19 2016-09-28 Ultrasonic bath to increase tissue perfusion

Country Status (2)

Country Link
US (3) US9050448B2 (en)
WO (1) WO2008077096A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008077096A2 (en) * 2006-12-19 2008-06-26 Cedars-Sinai Medical Center Ultrasonic bath to increase tissue perfusion
CN102580259B (en) * 2012-03-05 2014-09-17 深圳市龙岗中心医院 Auxiliary tank for ultrasonic treatment of shank disease
US10485963B2 (en) * 2013-06-29 2019-11-26 Vaporox, Inc. Medical treatment system and method of use
US20150073311A1 (en) * 2013-09-08 2015-03-12 Moshe Ein-Gal Method and device for treating pathological conditions associated with bone and musculoskeletal environments
WO2023192365A1 (en) * 2022-03-29 2023-10-05 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Devices, systems, and methods for containment of an organ ex vivo and confluent distribution of an ultrasound field

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867929A (en) * 1970-03-20 1975-02-25 Linden Lab Inc Ultrasonic treatment device and methods for using the same
US4945901A (en) * 1989-03-22 1990-08-07 Burcke Jr Harry J Hand therapy apparatus and method therefor
US5178134A (en) * 1988-03-30 1993-01-12 Malmros Holding, Inc. Ultrasonic treatment of animals
US5524620A (en) * 1991-11-12 1996-06-11 November Technologies Ltd. Ablation of blood thrombi by means of acoustic energy
US6233481B1 (en) * 1997-10-09 2001-05-15 Spectra Science Corporation Diagnostic application of sono-chemical excitation of fluorescent photosensitizers
US20010004680A1 (en) * 1998-03-16 2001-06-21 Brotz Gregory R. Therapeutic stimulatory massage apparatus
US6312647B1 (en) * 1994-12-09 2001-11-06 Wayne State University Method for enriching a fluid with oxygen
US20020120225A1 (en) * 1998-05-29 2002-08-29 Mcdaniel David H. Ultrasound enhancement of percutaneous drug absorption
US6450979B1 (en) * 1998-02-05 2002-09-17 Miwa Science Laboratory Inc. Ultrasonic wave irradiation apparatus
US20020156400A1 (en) * 2001-04-23 2002-10-24 Eilaz Babaev Ultrasonic method and device for wound treatment
US20050019744A1 (en) * 2003-07-25 2005-01-27 La Jolla Bioengineering Institute Ultrasound-assisted ischemic reperfusion
US8361001B2 (en) * 2002-12-31 2013-01-29 Otivio As Device for applying a pulsating pressure to a local region of the body and the applications thereof

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3023611A (en) * 1956-03-19 1962-03-06 Douglass H Howry Ultrasonic method and apparatus for investigating the interior structure of solid bodies
US2970073A (en) * 1959-10-28 1961-01-31 Howe Sound Co Method for ultrasonic surgical cleaning of human body members
US3499436A (en) * 1967-03-10 1970-03-10 Ultrasonic Systems Method and apparatus for treatment of organic structures with coherent elastic energy waves
US3550586A (en) * 1967-03-10 1970-12-29 Ultrasonic Systems Ultrasonic treatment method and device for fertilized ova and live embryos
US3765403A (en) * 1968-05-20 1973-10-16 Holotron Corp Ultrasonic imaging techniques and mammograph equipment
US4216766A (en) * 1979-09-07 1980-08-12 The United States Of America As Represented By The Secretary Of The Navy Treatment of body tissue by means of internal cavity resonance
US4787394A (en) * 1986-04-24 1988-11-29 Kabushiki Kaisha Toshiba Ultrasound therapy apparatus
US4786277A (en) * 1986-11-21 1988-11-22 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation
US4780212A (en) * 1987-07-31 1988-10-25 Massachusetts Institute Of Technology Ultrasound enchancement of membrane permeability
US4905671A (en) * 1988-01-11 1990-03-06 Dornier Medizintechnik Gmbh Inducement of bone growth by acoustic shock waves
US5665141A (en) * 1988-03-30 1997-09-09 Arjo Hospital Equipment Ab Ultrasonic treatment process
US4942868A (en) * 1988-03-30 1990-07-24 Malmros Holding, Inc. Ultrasonic treatment of animals
US5048520A (en) * 1988-03-30 1991-09-17 Malmros Holding, Inc. Ultrasonic treatment of animals
US5086788A (en) * 1988-06-13 1992-02-11 Castel John C Hand-held physiological stimulation applicator
US6088613A (en) * 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5149319A (en) * 1990-09-11 1992-09-22 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids
US5318035A (en) * 1991-12-02 1994-06-07 Nitto Denko Corporation Crosslinked molding, sound medium using it and ultrasonic coupler
CA2100728C (en) * 1993-07-16 2005-10-11 William H. Kemp Ultrasonic bathing system
US5413550A (en) * 1993-07-21 1995-05-09 Pti, Inc. Ultrasound therapy system with automatic dose control
US5595178A (en) * 1994-10-02 1997-01-21 Hmt High Medical Technologies Gmbh System, method and apparatus for treatment of degenerative bone
US5693004A (en) * 1996-03-11 1997-12-02 Lord Corporation Controllable fluid rehabilitation device including a reservoir of fluid
US7416535B1 (en) * 1996-12-30 2008-08-26 Daniele Kenny Neoplastic cell destruction device and method utilizing low frequency sound waves to disrupt or displace cellular materials
US7108663B2 (en) * 1997-02-06 2006-09-19 Exogen, Inc. Method and apparatus for cartilage growth stimulation
US6390995B1 (en) * 1997-02-12 2002-05-21 Healthtronics Surgical Services, Inc. Method for using acoustic shock waves in the treatment of medical conditions
US5904659A (en) * 1997-02-14 1999-05-18 Exogen, Inc. Ultrasonic treatment for wounds
KR20010006564A (en) * 1997-04-18 2001-01-26 텔리쉬, 로저 제이. Submersible system for ultrasonic treatment
US6047246A (en) * 1997-05-23 2000-04-04 Vickers; John W. Computer-controlled ultrasonic cleaning system
US6398753B2 (en) * 1998-04-03 2002-06-04 Mcdaniel David H. Ultrasound enhancement of percutaneous drug absorption
JP4828699B2 (en) * 1998-09-11 2011-11-30 ジーアール インテレクチュアル リザーブ リミティド ライアビリティ カンパニー Use of resonant acoustics and / or resonant acoustic-EM energy to detect and / or act on structures
US6206843B1 (en) * 1999-01-28 2001-03-27 Ultra Cure Ltd. Ultrasound system and methods utilizing same
US6291180B1 (en) * 1999-09-29 2001-09-18 American Registry Of Pathology Ultrasound-mediated high-speed biological reaction and tissue processing
GB2363386B (en) * 2000-06-16 2004-07-28 Chesham Chemicals Ltd Fluid gel comprising xanthan and non-gelling polysaccharides
US7559895B2 (en) * 2000-07-07 2009-07-14 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Combining tomographic images in situ with direct vision using a holographic optical element
US6733450B1 (en) * 2000-07-27 2004-05-11 Texas Systems, Board Of Regents Therapeutic methods and apparatus for use of sonication to enhance perfusion of tissue
US20020115960A1 (en) * 2000-08-24 2002-08-22 Redding Bruce K. Substance delivery system
US6964647B1 (en) * 2000-10-06 2005-11-15 Ellaz Babaev Nozzle for ultrasound wound treatment
US6569099B1 (en) * 2001-01-12 2003-05-27 Eilaz Babaev Ultrasonic method and device for wound treatment
US6908448B2 (en) * 2001-08-24 2005-06-21 Dermisonics, Inc. Substance delivery device
US7175596B2 (en) * 2001-10-29 2007-02-13 Insightec-Txsonics Ltd System and method for sensing and locating disturbances in an energy path of a focused ultrasound system
WO2003064981A1 (en) * 2002-01-28 2003-08-07 Matsushita Electric Industrial Co., Ltd. Acoustic matching layer, ultrasonic transmitter/receiver, and ultrasonic flowmeter
AU2003234385A1 (en) * 2002-05-09 2003-11-11 Michael S. Brogan Electrical stimulation unit and waterbath system
CA2484515A1 (en) * 2002-05-30 2003-12-11 University Of Washington Solid hydrogel coupling for ultrasound imaging and therapy
US20040087883A1 (en) * 2002-10-31 2004-05-06 Berger William H. Pedicure foot bath
US6884227B2 (en) * 2002-11-08 2005-04-26 Juvent, Inc. Apparatuses and methods for therapeutically treating damaged tissues, bone fractures, osteopenia, or osteoporosis
US8353853B1 (en) * 2003-01-24 2013-01-15 Boston Scientific Scimed, Inc. Encephalic insonication
US8870796B2 (en) * 2003-09-04 2014-10-28 Ahof Biophysical Systems Inc. Vibration method for clearing acute arterial thrombotic occlusions in the emergency treatment of heart attack and stroke
US7377905B2 (en) * 2003-10-01 2008-05-27 Robert Vago Method and device for subaqueous ultrasonic irradiation of living tissue
US7393323B2 (en) * 2003-10-01 2008-07-01 Robert Vago Method and device for subaqueous ultrasonic irradiation of living tissue
US7491200B2 (en) * 2004-03-26 2009-02-17 Arthrocare Corporation Method for treating obstructive sleep disorder includes removing tissue from base of tongue
US7413552B2 (en) * 2004-08-05 2008-08-19 Robert Vago Method for subaqueous ultrasonic catastrophic irradiation of living tissue
US20060094988A1 (en) * 2004-10-28 2006-05-04 Tosaya Carol A Ultrasonic apparatus and method for treating obesity or fat-deposits or for delivering cosmetic or other bodily therapy
CA2610561A1 (en) * 2005-06-02 2006-12-07 Cancercure Technology As Ultrasound treatment system
US8057408B2 (en) * 2005-09-22 2011-11-15 The Regents Of The University Of Michigan Pulsed cavitational ultrasound therapy
US20070167882A1 (en) * 2005-12-13 2007-07-19 Mauro Guzzini Cosmetic treatment and relative apparatus
WO2008013524A2 (en) * 2006-07-24 2008-01-31 Iyia Technologies, Inc. Wound treatment system and method of use
WO2008077096A2 (en) * 2006-12-19 2008-06-26 Cedars-Sinai Medical Center Ultrasonic bath to increase tissue perfusion
US8603014B2 (en) * 2010-10-05 2013-12-10 Cerevast Therapeutics, Inc. Hands-free operator-independent transcranial ultrasound apparatus and methods

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867929A (en) * 1970-03-20 1975-02-25 Linden Lab Inc Ultrasonic treatment device and methods for using the same
US5178134A (en) * 1988-03-30 1993-01-12 Malmros Holding, Inc. Ultrasonic treatment of animals
US4945901A (en) * 1989-03-22 1990-08-07 Burcke Jr Harry J Hand therapy apparatus and method therefor
US5524620A (en) * 1991-11-12 1996-06-11 November Technologies Ltd. Ablation of blood thrombi by means of acoustic energy
US6312647B1 (en) * 1994-12-09 2001-11-06 Wayne State University Method for enriching a fluid with oxygen
US6233481B1 (en) * 1997-10-09 2001-05-15 Spectra Science Corporation Diagnostic application of sono-chemical excitation of fluorescent photosensitizers
US6450979B1 (en) * 1998-02-05 2002-09-17 Miwa Science Laboratory Inc. Ultrasonic wave irradiation apparatus
US20010004680A1 (en) * 1998-03-16 2001-06-21 Brotz Gregory R. Therapeutic stimulatory massage apparatus
US20020120225A1 (en) * 1998-05-29 2002-08-29 Mcdaniel David H. Ultrasound enhancement of percutaneous drug absorption
US20020156400A1 (en) * 2001-04-23 2002-10-24 Eilaz Babaev Ultrasonic method and device for wound treatment
US8361001B2 (en) * 2002-12-31 2013-01-29 Otivio As Device for applying a pulsating pressure to a local region of the body and the applications thereof
US20050019744A1 (en) * 2003-07-25 2005-01-27 La Jolla Bioengineering Institute Ultrasound-assisted ischemic reperfusion

Also Published As

Publication number Publication date
US20100063423A1 (en) 2010-03-11
WO2008077096A2 (en) 2008-06-26
WO2008077096A3 (en) 2008-08-07
US20170113068A1 (en) 2017-04-27
US9050448B2 (en) 2015-06-09

Similar Documents

Publication Publication Date Title
US20170113068A1 (en) Ultrasonic bath to increase tissue perfusion
Alizadeh et al. Review of the mechanisms and effects of noninvasive body contouring devices on cellulite and subcutaneous fat
Schaden et al. Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study
US8956387B2 (en) Systems for replicating the beneficial effects of physical exercise and improving cardiovascular health
US12109441B2 (en) Extracorporeal therapeutic ultrasound for promoting vasodilation
JP2009511226A (en) Apparatus and method for treating damaged soft tissue
Andersson et al. Tissue memory in healing tendons: short loading episodes stimulate healing
CA2783067A1 (en) Heat stimulus applying apparatus
CA2483412A1 (en) Procedure and machine for electro-inducing/stimulating deep-layered muscle contractions using a biphasic faradic pulse sequence
Morris Intermittent pneumatic compression—systems and applications
JP2007530209A (en) Electromagnetic devices for treating inappropriate blood perfusion, partial denervation, tissue loss, pain, edema, inflammation, and infectious damage
CN103384548A (en) Skin ulcer treatment
Ostrowski et al. Effectiveness of salted ice bag versus cryocompression on decreasing intramuscular and skin temperature
US11951335B2 (en) Internal organ, injury and pain, pulmonary condition and adipose tissue treatment
Johannsen et al. Ultrasound therapy in chronic leg ulceration: a meta‐analysis
Li et al. Effects of ankle pump exercise frequency on venous hemodynamics of the lower limb
US20230093814A1 (en) Extracorporeal therapeutic ultrasound for promoting angiogenesis
Gogia et al. Wound management with whirlpool and infrared cold laser treatment: a clinical report
Poelkens et al. Counteracting venous stasis during acute lower leg immobilization
Reyes et al. Report from the 2013 meeting of the International Compression Club on advances and challenges of compression therapy
Clarke-Moloney et al. A review of technological approaches to venous ulceration
CN208481694U (en) A kind of smoked washing machine
RU2289386C2 (en) Method of ultrasonic physiotherapy in liquid
Faily et al. The use of subcutaneous drainage for the management of lower extremity edema in cancer patients
RU2762908C1 (en) Method for lower limbs varicose disease treatment

Legal Events

Date Code Title Description
AS Assignment

Owner name: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIRNBAUM, YOCHAI;REEL/FRAME:035545/0673

Effective date: 20090616

Owner name: CEDARS-SINAI MEDICAL CENTER, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SIEGEL, ROBERT J.;LUO, HUAI;REEL/FRAME:035545/0587

Effective date: 20090508

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION